Select your country
Websites worldwide
Select a country to go to the website of the respective STADA sales company.
Australia (1)
Belarus (1)
Belgium (1)
Bosnia-Herzegovina (1)
Bulgaria (1)
China (1)
Croatia (1)
Czech Republic (2)
Denmark (1)
France (1)
Hungary (1)
Ireland (1)
Italy (1)
Montenegro (1)
Netherlands (2)
Poland (1)
Portugal (1)
Romania (1)
Saudi Arabia (1)
Serbia (1)
Slovakia (1)
Slovenia (1)
Spain (1)
Switzerland (1)
The Phillippines (1)
United Arab Emirates (1)
United Kingdom (3)
Vietnam (2)
Bone Health represent a considerable health challenge around the world. Globally, osteoporosis causes more than 8.9 million fractures annually, with the disease affecting approximately 21.2% of women and 6.3% of men aged over 50.1 Across 29 European countries, the direct cost of osteoporotic fractures in 2019 has been calculated at €56.9 billion.2
STADA contributes to managing both the disease burden and the resulting costs through bringing competition to the biologic medicines market in Europe. This medicine for post-menopausal women and men at increased risk of fractures is administered with a reusable pen injector, assisting patients in managing their own health.
